Malignant Neoplasms
|
1641
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.080 |
0.500 |
8 |
2016 |
2019 |
Primary malignant neoplasm
|
1374
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.080 |
0.500 |
8 |
2016 |
2019 |
Breast Carcinoma
|
2793
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.030 |
0.667 |
3 |
2017 |
2018 |
Malignant neoplasm of breast
|
3417
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.030 |
0.667 |
3 |
2017 |
2018 |
Carcinoma of lung
|
1204
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.020 |
1.000 |
2 |
2018 |
2018 |
Carcinoma, Ovarian Epithelial
|
327
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.020 |
1.000 |
2 |
2016 |
2018 |
Malignant neoplasm of lung
|
1142
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.020 |
1.000 |
2 |
2018 |
2018 |
Primary malignant neoplasm of lung
|
981
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.020 |
1.000 |
2 |
2018 |
2018 |
Adenocarcinoma of lung (disorder)
|
563
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2018 |
2018 |
Benign Prostatic Hyperplasia
|
91
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2017 |
2017 |
cervical cancer
|
268
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Cervix carcinoma
|
283
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Congenital heart disease
|
80
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2018 |
2018 |
Epithelial ovarian cancer
|
129
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Ewings sarcoma-primitive neuroectodermal tumor (PNET)
|
3
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2019 |
2019 |
Giant Cell Arteritis
|
78
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Malignant neoplasm of ovary
|
315
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2018 |
2018 |
Malignant neoplasm of pancreas
|
277
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2019 |
2019 |
Malignant neoplasm of prostate
|
1082
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2017 |
2017 |
Malignant neoplasm of stomach
|
615
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Malignant tumor of cervix
|
245
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Neoplasms
|
1644
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2019 |
2019 |
Neuroectodermal Tumor, Primitive
|
6
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2019 |
2019 |
ovarian neoplasm
|
757
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2018 |
2018 |
Pancreatic carcinoma
|
322
|
0.649 |
0.440 |
12 |
53968051 |
non coding transcript exon variant |
G/A
|
snv |
|
0.93
|
0.010 |
1.000 |
1 |
2019 |
2019 |